Freudenberg Medical has completed construction of a medical manufacturing operation in Beverly, Massachusetts. The company has established the facility as its global headquarters and the location will manufacture medical devices and components in medical and implant-grade silicones and high-performance plastics.
The 36,000 sqft operation includes expanded manufacturing facilities and Class 8 cleanroom space for molding and assembly. The operation is ISO 13485 certified and FDA-registered.
“The Boston life science cluster is the ideal place for our new headquarters and expanded manufacturing operation. It brings us closer to our customers, provides access to a strong medtech workforce and allows us to connect with local universities and research institutes,” said Max Kley, President and CEO of Freudenberg Medical.
“As a values-based global technology group Freudenberg offers innovative solutions that improve peoples’ lives. The opening of this new facility at this challenging moment is the proof of our long-term commitment and determination to continue this pursuit, drawing on our worldwide materials expertise to improve life-saving medical tools and components,” says Freudenberg CEO Dr Mohsen Sohi.
